[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …
Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of
morbidity and mortality in patients with established disease. Secular trends in the …
morbidity and mortality in patients with established disease. Secular trends in the …
Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis
Purpose This study aimed at analyzing the prevalence, mortality association, and risk factors
for bleeding and thrombosis events (BTEs) among adults supported with venovenous …
for bleeding and thrombosis events (BTEs) among adults supported with venovenous …
Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart …
N Uriel, PC Colombo, JC Cleveland, JW Long… - Circulation, 2017 - Am Heart Assoc
Background: The HeartMate 3 (HM3) Left Ventricular Assist System (LVAS)(Abbott) is a
centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance …
centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance …
[HTML][HTML] PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study
Background Recommended structured clinical practices including implant technique, anti-
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …
Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study
Abstract Background: The HeartMate 3 left ventricular assist system (LVAS) is intended to
provide long-term support to patients with advanced heart failure. The centrifugal flow pump …
provide long-term support to patients with advanced heart failure. The centrifugal flow pump …
INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes
D Acharya, R Loyaga-Rendon, CJ Morgan, KA Sands… - JACC: Heart Failure, 2017 - jacc.org
Objectives: This study sought to evaluate predictors of stroke during left ventricular assist
device (LVAD) support from data available prior to implantation, and quantify stroke-related …
device (LVAD) support from data available prior to implantation, and quantify stroke-related …
Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 study: a randomized controlled trial of the HeartMate 3 versus the HeartMate II cardiac …
PC Colombo, MR Mehra, DJ Goldstein, JD Estep… - Circulation, 2019 - Am Heart Assoc
Background: The MOMENTUM 3 study (Multicenter Study of MagLev Technology in Patients
Undergoing Mechanical Circulatory Support Therapy With HeartMate 3) has demonstrated …
Undergoing Mechanical Circulatory Support Therapy With HeartMate 3) has demonstrated …
Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices
Background Stroke is a major cause of mortality after left ventricular assist device (LVAD)
placement. Methods Prospectively collected data of patients with HeartMate II (n= 332) and …
placement. Methods Prospectively collected data of patients with HeartMate II (n= 332) and …
Cerebrovascular events in patients with centrifugal-flow left ventricular assist devices: propensity score–matched analysis from the Intermacs registry
Background: Ischemic and hemorrhagic cerebrovascular accidents remain common among
patients with centrifugal-flow left ventricular assist devices, despite improvements in survival …
patients with centrifugal-flow left ventricular assist devices, despite improvements in survival …